NO970665L - Blod billeddannende sammensetninger, anvendelse og fremgangsmåte - Google Patents

Blod billeddannende sammensetninger, anvendelse og fremgangsmåte

Info

Publication number
NO970665L
NO970665L NO970665A NO970665A NO970665L NO 970665 L NO970665 L NO 970665L NO 970665 A NO970665 A NO 970665A NO 970665 A NO970665 A NO 970665A NO 970665 L NO970665 L NO 970665L
Authority
NO
Norway
Prior art keywords
compositions
circulation
mixed micelles
mri
physiologically acceptable
Prior art date
Application number
NO970665A
Other languages
English (en)
Other versions
NO314127B1 (no
NO970665D0 (no
Inventor
Herve Tournier
Bernard Lamy
Roland Hyacinthe
Original Assignee
Bracco Research Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8221760&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO970665(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bracco Research Sa filed Critical Bracco Research Sa
Publication of NO970665D0 publication Critical patent/NO970665D0/no
Publication of NO970665L publication Critical patent/NO970665L/no
Publication of NO314127B1 publication Critical patent/NO314127B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1806—Suspensions, emulsions, colloids, dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Radiology & Medical Imaging (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
NO19970665A 1995-06-15 1997-02-13 Injiserbare NMR-billeddannende sammensetninger, fremgangsmåter for fremstilling og anvendelse av disse NO314127B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP95810403 1995-06-15
PCT/IB1996/000577 WO1997000087A1 (en) 1995-06-15 1996-06-14 Blood-pool imaging compositions use and method

Publications (3)

Publication Number Publication Date
NO970665D0 NO970665D0 (no) 1997-02-13
NO970665L true NO970665L (no) 1997-04-03
NO314127B1 NO314127B1 (no) 2003-02-03

Family

ID=8221760

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19970665A NO314127B1 (no) 1995-06-15 1997-02-13 Injiserbare NMR-billeddannende sammensetninger, fremgangsmåter for fremstilling og anvendelse av disse

Country Status (13)

Country Link
US (1) US5833948A (no)
EP (1) EP0804251B1 (no)
JP (1) JP4335976B2 (no)
KR (1) KR100399712B1 (no)
AT (1) ATE224737T1 (no)
AU (1) AU708328B2 (no)
CA (1) CA2195633C (no)
DE (1) DE69623929T2 (no)
ES (1) ES2180784T3 (no)
NO (1) NO314127B1 (no)
PT (1) PT804251E (no)
WO (1) WO1997000087A1 (no)
ZA (1) ZA965101B (no)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1297034B1 (it) * 1997-12-30 1999-08-03 Bracco Spa Acido 1,4,7,10-tetraazaciclododecan-1,4-diacetico
IT1297035B1 (it) * 1997-12-30 1999-08-03 Bracco Spa Derivati dell'acido 1,4,7,10-tetraazaciclododecan-1,4-diacetico
US6342598B1 (en) 1998-11-26 2002-01-29 Bracco International B.V. Amphipatic polycarboxylic chelates and complexes with paramagnetic metals as MRI contrast agents
IT1304501B1 (it) * 1998-12-23 2001-03-19 Bracco Spa Uso di derivati di acidi biliari coniugati con complessi metallicicome "blood pool agents" per l'indagine diagnostica tramite risonanza
AU2001266696A1 (en) 2000-06-02 2001-12-11 Bracco Research Usa Compounds for targeting endothelial cells
US6984395B2 (en) * 2001-04-11 2006-01-10 Qlt, Inc. Drug delivery system for hydrophobic drugs
US20070128253A1 (en) * 2005-04-13 2007-06-07 Ramaekers Joseph C Encapsulated transfer factor compositions and methods of use
US20060073197A1 (en) * 2004-05-20 2006-04-06 Ramaekers Joseph C Encapsulated transfer factor compositions and methods of use
US6506413B1 (en) * 2001-04-30 2003-01-14 Joseph C. Ramaekers Compositions for treating animal diseases and syndromes
US6803046B2 (en) 2002-08-16 2004-10-12 Bracco International B.V. Sincalide formulations
US7553930B2 (en) * 2003-01-06 2009-06-30 Xencor, Inc. BAFF variants and methods thereof
US20050221443A1 (en) * 2003-01-06 2005-10-06 Xencor, Inc. Tumor necrosis factor super family agonists
US20050130892A1 (en) * 2003-03-07 2005-06-16 Xencor, Inc. BAFF variants and methods thereof
US20060014248A1 (en) * 2003-01-06 2006-01-19 Xencor, Inc. TNF super family members with altered immunogenicity
JP4670083B2 (ja) 2003-02-04 2011-04-13 ブラッコ・シュイス・ソシエテ・アノニム 超音波造影剤およびその製造方法
EP1675871A2 (en) 2003-10-10 2006-07-05 Xencor Inc. Protein based tnf-alpha variants for the treatment of tnf-alpha related disorders
CN100563718C (zh) 2003-12-22 2009-12-02 伯拉考开发股份有限公司 用于反差成像的充气微囊组件
US20050152842A1 (en) * 2003-12-24 2005-07-14 Chun Li Poly (L-glutamic acid) paramagnetic material complex and use as a biodegradable MRI contrast agent
EP1750671B1 (en) * 2004-06-03 2008-10-15 Bracco Research S.A. Liposomal assembly for therapeutic and/or diagnostic use
US9248204B2 (en) 2004-08-18 2016-02-02 Bracco Suisse S.A. Gas-filled microvesicles composition for contrast imaging
FR2883562B1 (fr) 2005-03-24 2009-02-27 Guerbet Sa Chelates lipophiles et leur utilisation en imagerie
RU2007140391A (ru) * 2005-04-01 2009-05-10 Дзе Борд Оф Риджентс Оф Дзе Юниверсити Оф Техас Систем (Us) Поли(пептид) как хелатор: способы получения и применения
EP1898958A2 (en) * 2005-05-31 2008-03-19 INBIOS S.r.l. Supramolecular aggregates containing chelating agents and bioactive peptides as effective and selective delivery tools for drugs and contrast agents in mri or nuclear medicine
US20090053197A1 (en) * 2006-06-14 2009-02-26 Ramaekers Joseph C Transfer Factor Compositions and Methods
US9125874B2 (en) 2007-11-30 2015-09-08 The Ramaekers Family Trust Administration of transfer factor for improving reproductive health
ATE469660T1 (de) 2006-09-05 2010-06-15 Bracco Research Sa Gasgefüllte mikrovesikel mit polymer- modifizierten lipiden
GB0623838D0 (en) * 2006-11-29 2007-01-10 Malvern Cosmeceutics Ltd Novel compositions
US20090074751A1 (en) * 2007-09-18 2009-03-19 Ramaekers Nutrition, Inc. Growth factor fraction compositions and methods
KR101401217B1 (ko) * 2007-11-07 2014-05-28 충남대학교산학협력단 Ｐｅ－ｄｔｐａ의 새로운 용도
MX2010005317A (es) 2007-11-20 2010-06-02 Ambrx Inc Polipeptidos de insulina modificados y sus usos.
WO2009070788A1 (en) * 2007-11-30 2009-06-04 The Ramaekers Family Trust Compositions and methods for enhancing fertility
WO2009097559A1 (en) 2008-01-30 2009-08-06 Histogen, Inc. Extracellular matrix compositions
CN106362171A (zh) 2009-02-13 2017-02-01 华盛顿大学 用于磁共振成像的钆表现脂质纳米颗粒
WO2010139003A1 (en) * 2009-06-01 2010-12-09 Commonwealth Scientific And Industrial Research Organisation Chelating amphiphiles
MA34521B1 (fr) 2010-08-17 2013-09-02 Ambrx Inc Polypeptides de relaxine modifiés et leurs utilisations
EP2639227A1 (en) 2012-03-14 2013-09-18 Bracco Imaging S.p.A A new class of diazepine derivative chelating agents and complexes with paramagnetic metals as MRI contrast agents
WO2014037498A2 (en) 2012-09-07 2014-03-13 Bracco Imaging Spa Paramagnetic solid lipid nanoparticles (pslns) containing metal amphiphilic complexes for mri.
WO2014040076A1 (en) 2012-09-10 2014-03-13 Xencor Methods of treating neurological diseases
EP2934740B1 (en) 2012-12-21 2019-12-11 Bracco Suisse SA Gas-filled microvesicles
WO2015119642A1 (en) 2014-02-10 2015-08-13 The Johns Hopkins University Low oxygen tension enhances endothelial fate of human pluripotent stem cells
US10519207B2 (en) 2015-06-12 2019-12-31 Georgia State University Research Foundation, Inc. Compositions and methods for treating opioid tolerance
US11110063B2 (en) 2017-08-25 2021-09-07 MAIA Pharmaceuticals, Inc. Storage stable sincalide formulations
US12077780B2 (en) 2020-02-14 2024-09-03 Allergan Sales, Llc Conditioned medium from cells cultured under hypoxic conditions and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5387410A (en) * 1983-03-18 1995-02-07 Mallinckrodt, Inc. Method for enhancing magnetic resonance with compositions containing paramagnetic elements carried by liposomes
US4728575A (en) * 1984-04-27 1988-03-01 Vestar, Inc. Contrast agents for NMR imaging
US5215680A (en) * 1990-07-10 1993-06-01 Cavitation-Control Technology, Inc. Method for the production of medical-grade lipid-coated microbubbles, paramagnetic labeling of such microbubbles and therapeutic uses of microbubbles
JPH06507904A (ja) * 1991-05-23 1994-09-08 イマアーレクス・フアーマシユーチカル・コーポレーシヨン 磁気共鳴画像形成用の油脂可溶化合物
US5464696A (en) * 1992-08-13 1995-11-07 Bracco International B.V. Particles for NMR imaging
US5534241A (en) * 1993-07-23 1996-07-09 Torchilin; Vladimir P. Amphipathic polychelating compounds and methods of use
US5567410A (en) * 1994-06-24 1996-10-22 The General Hospital Corporation Composotions and methods for radiographic imaging

Also Published As

Publication number Publication date
ZA965101B (en) 1997-01-22
JPH10504044A (ja) 1998-04-14
EP0804251B1 (en) 2002-09-25
CA2195633C (en) 2008-09-16
EP0804251A1 (en) 1997-11-05
ES2180784T3 (es) 2003-02-16
DE69623929D1 (de) 2002-10-31
CA2195633A1 (en) 1997-01-03
US5833948A (en) 1998-11-10
NO314127B1 (no) 2003-02-03
AU5843196A (en) 1997-01-15
KR970704477A (ko) 1997-09-06
JP4335976B2 (ja) 2009-09-30
WO1997000087A1 (en) 1997-01-03
AU708328B2 (en) 1999-08-05
NO970665D0 (no) 1997-02-13
PT804251E (pt) 2003-01-31
KR100399712B1 (ko) 2004-02-18
DE69623929T2 (de) 2003-05-15
ATE224737T1 (de) 2002-10-15

Similar Documents

Publication Publication Date Title
NO970665D0 (no) Blod billeddannende sammensetninger, anvendelse og fremgangsmåte
IL125895A0 (en) The use of an image enhancing moiety in the preparation of bioactivated nmr or optical imaging contrat agent from a prodrug
EP0994352A3 (en) Contrast agent enhanced magnetic resonance imaging of myocardial tissue
Chin et al. Magnetic resonance imaging for detecting and treatment monitoring of orthotopic murine bladder tumor implants
Winn et al. Individual and combined effects of relaxin, estrogen, and progesterone in ovariectomized gilts. II. Effects on mammary development
GB9716365D0 (en) Improvements in or relating to magnetic resonance imaging
Gorospe et al. Ewing’s sarcoma of the mandible: radiologic features with emphasis on magnetic resonance appearance
IL117248A (en) Liposome suspensions as carriers of blood-pool imaging contrast agents and methods for preparing the same
Wang et al. Vertebral blood perfusion reduction associated with vertebral bone mineral density reduction: A dynamic contrast‐enhanced MRI study in a rat orchiectomy model
Raroque et al. Neoplastic angioendotheliomatosis
Lutsep et al. Does reversal of ischemia on diffusion‐weighted imaging reflect higher apparent diffusion coefficient values?
Taori et al. Aneurysmal bone cyst of talus: a rare case
Li Adaptation Of Maternal Skeletal Mechano-Responsiveness, Osteocyte Microenvironment, And Bone Marrow Adipocytes In Response To Reproduction And Lactation
LODGE et al. Reproducibility of quantitative permeability measurements in dynamic contrast-enhanced MRI studies
Gates et al. Neuroimaging of fractureless transforamen magnum penetrating injury of the cerebellum
Katsumata et al. Magnetic resonance imaging of murine schistosomiasis
Craig et al. Mummified child–a further investigation
Junior et al. Magnetic resonance imaging perfusion technique in the evaluation of achilles tendon injury in rabbits
Tavares et al. Magnetic resonance imaging perfusion technique in the evaluation of achilles tendon injury in rabbits
Hirata et al. The incidence of eosinophilic inclusions inside schistosoma japonicum eggs negatively correlate with the granuloma development
Zhou et al. A preliminary study on the serum levels of IL-4 in schistosomiasis japonica patients after treatment with praziquantel and its clinical significance
Friedrich et al. Noninvasive diagnosis of acute myocarditis by contrast-enhanced magnetic resonance imaging
Kim et al. Functional Imaging of Cerebral Cortex Activation with a 1.5-T IVIR Imaging System
Niehoff et al. Electron beam portal imaging for routine documentation in radiation therapy
Fritton Mechanical loading induced adaptation of the mouse tibia

Legal Events

Date Code Title Description
CB Opposition filed (par. 26,5 patents act)

Opponent name: AMERSHAM HEALTH AS, POSTBOKS 4220 NYDALEN, 0401 OS

Effective date: 20031104

ERR Erratum

Free format text: I PATENTTIDENDE NR 47 BLE INNSIGELSE I PATENT NR 314127 KUNNGJORT MED FEIL INNSIGELSESDAG.

MM1K Lapsed by not paying the annual fees